1623 Capital LLC Zoetis Inc. Transaction History

1623 Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$145.54 - $178.83 $14,554 - $17,883	100 Added 0.35%	28,800 $4.99 Million
Q1 2024 May 14, 2024	BUY	$165.67 - $199.94 $49,700 - $59,982	300 Added 1.06%	28,700 $4.86 Million
Q2 2023 Aug 11, 2023	BUY	$160.94 - $186.23 $55,685 - $64,435	346 Added 1.23%	28,400 $4.89 Million
Q4 2022 Feb 10, 2023	BUY	$131.14 - $157.47 $216,905 - $260,455	1,654 Added 6.27%	28,054 $4.11 Million
Q1 2021 May 14, 2021	BUY	$144.0 - $169.39 $201,600 - $237,145	1,400 Added 5.6%	26,400 $4.16 Million
Q4 2020 Feb 12, 2021	BUY	$157.07 - $174.35 $799,329 - $887,267	5,089 Added 25.56%	25,000 $4.14 Million
Q1 2020 May 13, 2020	BUY	$92.66 - $144.94 $114,435 - $179,000	1,235 Added 6.61%	19,911 $2.34 Million
Q4 2019 May 01, 2020	BUY	$116.25 - $133.25 $2.17 Million - $2.49 Million	18,676 New	18,676 $2.47 Million

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of 1623 Capital LLC, based on Form 13F filings with the SEC.

Stay updated on 1623 Capital LLC with notifications on news.